MMJ Group Holdings Limited (ASX: MMJ) ("MMJ") is pleased to attach a copy of a news release by MediPharm Labs Inc (“MediPharm Labs”) (TSX-V: LABS) (OTCQB: MLCPF) announcing that it has entered into a multi-year cannabis extraction agreement with TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend”).
MMJ owns approximately 4.4 million shares for a 4.5% shareholding (at a cost of CAD$0.85 per share) and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in
MediPharm Labs.
For more information, download the attached PDF.
Download this document
